MITA/STING and its alternative splicing isoform MRP restrict hepatitis B virus replication

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Liu, Shuhui ^a,b   Zhao, Kaitao ^a,b   Su, Xi ^a,b   Lu, Lu ^c,e   Zhao, He ^a   Zhang, Xianwen ^a,b   Wang, Yun ^a   Wu, Chunchen ^a   Chen, Jizheng ^a   Zhou, Yuan ^a   Hu, Xue ^a   Wang, Yanyi ^a   Lu, Mengji ^d   Chen, Xinwen ^a   Pei, Rongjuan ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e Jiangdong Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 6; MITA PROTEIN; MITA RELATED PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ISOPROTEIN; MEMBRANE PROTEIN; MPYS PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HEPATITIS B VIRUS; HUMORAL IMMUNITY; INNATE IMMUNITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS REPLICATION; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; LIVER; METABOLISM; NORTHERN BLOTTING; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIVER; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 85008686791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0169701     Document Type: Article

References (59)

1. Kakimi K, Lane TE, Wieland S, Asensio VC, Campbell IL, Chisari FV, et al. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med. 2001; 194(12):1755-66. PubMed Central PMCID: PMC2193580. PMID: 11748277.
2. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. Journal of Virology. 2003; 77(1):68-76. doi:10.1128/JVI.77.1.68-76.2003 PMID: 12477811.
3. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science. 1999; 284(5415):825-9. PMID: 10221919.
4. Han Q, Zhang C, Zhang J, Tian Z. The role of innate immunity in HBV infection. Semin Immunopathol. 2013; 35(1):23-38. doi:10.1007/s00281-012-0331-y PMID: 22814721.
5. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005; 17(1):1-14. doi:10.1093/intimm/dxh186 PMID: 15585605.
6. Fritz JH, Girardin SE. How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J Endotoxin Res. 2005; 11(6):390-4. doi:10.1179/096805105X76850 PMID: 16303096.
7. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, et al. LGP2 is a positive regulator of RIG-I-And MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A. 2010; 107(4):1512-7. PubMed Central PMCID: PMC2824407. doi:10.1073/pnas.0912986107 PMID: 20080593.
8. Rathinam VAK, Jiang ZZ, Waggoner SN, Sharma S, Cole LE, Waggoner L, et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nature Immunology. 2010; 11(5):395-403. doi:10.1038/ni.1864 PMID: 20351692.
9. Fernandes-Alnemri T, Yu JW, Datta P, Wu JH, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature. 2009; 458(7237): U509-U5. doi:10.1038/nature07710PMID: 19158676.
10. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-Activating inflammasome with ASC. Nature. 2009; 458 (7237): U514-U6. doi:10.1038/nature07725PMID: 19158675.
11. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 2010; 11(11):997-1004. PubMed Central PMCID: PMC3142795. doi:10.1038/ni.1932 PMID: 20890285.
12. Wang ZC, Choi MK, Ban T, Yanai H, Negishi H, Lu Y, et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. P Natl Acad Sci USA. 2008; 105(14):5477-82.
13. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol. 2011; 12(10):959-65. PubMed Central PMCID: PMC3671854. doi:10.1038/ni.2091 PMID: 21892174.
14. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013; 339(6121):826-30. PubMed Central PMCID: PMC3855410. doi:10.1126/science.1229963 PMID: 23258412.
15. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013; 339(6121):786-91. PubMed Central PMCID: PMC3863629. doi:10.1126/science.1232458 PMID: 23258413.
16. Ran Y, Shu HB, Wang YY. MITA/STING: A central and multifaceted mediator in innate immune response. Cytokine Growth Factor Rev. 2014; 25(6):631-9. doi:10.1016/j.cytogfr.2014.05.003 PMID: 24929887.
17. Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A. 2004; 101(17):6669-74. PubMed Central PMCID: PMC404103. doi:10.1073/pnas.0401771101 PMID: 15100412.
18. Luangsay S, Gruffaz M, Isorce N, Testoni B, Michelet M, Faure-Dupuy S, et al. Early inhibition of hepatocyte innate responses by hepatitis B virus. J Hepatol. 2015; 63(6):1314-22. doi:10.1016/j.jhep.2015.07.014PMID: 26216533.
19. Cui X, Clark DN, Liu K, Xu XD, Guo JT, Hu J. Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes. J Virol. 2015; 90(1):486-96. doi:10.1128/JVI.01263-15 PMID: 26491170.
20. Sato S, Li K, Kameyama T, Hayashi T, Ishida Y, Murakami S, et al. The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus. Immunity. 2015; 42(1):123- 32. doi:10.1016/j.immuni.2014.12.016 PMID: 25557055.
21. Hou ZH, Zhang J, Han QJ, Su CH, Qu J, Xu DQ, et al. Hepatitis B virus inhibits intrinsic RIG-I and RIGG immune signaling via inducing miR146a. Sci Rep-Uk. 2016; 6. doi:ARTN26150.
22. Wei CW, Ni CF, Song T, Liu Y, Yang XL, Zheng ZR, et al. The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein. Journal of Immunology. 2010; 185(2):1158-68.
23. Yu SY, Chen JL, Wu M, Chen H, Kato N, Yuan ZH. Hepatitis B virus polymerase inhibits RIG-I-And Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference withinterferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKK epsilon and DDX3. Journal of General Virology. 2010; 91:2080-90. doi:10.1099/vir.0.020552-0 PMID: 20375222.
24. Liu Y, Li J, Chen J, Li Y, Wang W, Du X, et al. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. J Virol. 2015; 89(4):2287-300. PubMed Central PMCID: PMC4338878. doi:10.1128/JVI.02760-14 PMID: 25505063.
25. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity. 2008; 29(4):538-50. doi:10.1016/j.immuni.2008.09.003 PMID: 18818105.
26. Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009; 461(7265):788-92. doi:10.1038/nature08476 PMID: 19776740.
27. Gao D, Wu J, Wu YT, Du F, Aroh C, Yan N, et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science. 2013; 341(6148):903-6. PubMed Central PMCID: PMC3860819. doi:10.1126/science.1240933 PMID: 23929945.
28. Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog. 2012; 8(10):e1002934. PubMed Central PMCID: PMC3464218. doi:10.1371/journal.ppat.1002934 PMID: 23055924.
29. Chen H, Pei R, Zhu W, Zeng R, Wang Y, Wang Y, et al. An alternative splicing isoform of MITA antagonizes MITA-mediated induction of type I IFNs. J Immunol. 2014; 192(3):1162-70. doi:10.4049/jimmunol.1300798 PMID: 24391220.
30. Guo F, Han YX, Zhao XS, Wang JG, Liu F, Xu CX, et al. STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus. Antimicrob Agents Ch. 2015; 59(2):1273-81.
31. Hu MM, Yang Q, Xie XQ, Liao CY, Lin H, Liu TT, et al. Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus. Immunity. 2016; 45(3):555-69. doi:10.1016/j.immuni.2016.08.014 PMID: 27637147.
32. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M. Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem. 1984; 259(17):10978-82. PMID: 6469994.
33. Sommer G, van Bommel F, Will H. Genotype-specific synthesis and secretion of spliced hepatitis B virus genomes in hepatoma cells. Virology. 2000; 271(2):371-81. doi:10.1006/viro.2000.0331 PMID: 10860890.
34. Stanssens P, Opsomer C, McKeown YM, Kramer W, Zabeau M, Fritz HJ. Efficient oligonucleotidedirected construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers. Nucleic Acids Res. 1989; 17(12):4441-54. PubMed Central PMCID: PMC318004. PMID: 2501754.
35. Cao L, Wu CC, Shi H, Gong ZJ, Zhang EJ, Wang H, et al. Coexistence of Hepatitis B Virus Quasispecies Enhances Viral Replication and the Ability To Induce Host Antibody and Cellular Immune Responses. Journal of Virology. 2014; 88(15):8656-66. doi:10.1128/JVI.01123-14 PMID: 24850745.
36. Qin B, Budeus B, Cao L, Wu C, Wang Y, Zhang X, et al. The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir. Antiviral Res. 2013; 97(2):93-100. doi:10.1016/j.antiviral.2012.12.007 PMID: 23261845.
37. Roychoudhury S, Faruqi AF, Shih C. Pregenomic RNA encapsidation analysis of eleven missense and nonsense polymerase mutants of human hepatitis B virus. J Virol. 1991; 65(7):3617-24. PubMed Central PMCID: PMC241367. PMID: 1710285.
38. Wu CC, Deng WY, Deng L, Cao L, Qin B, Li SX, et al. Amino Acid Substitutions at Positions 122 and 145 of Hepatitis B Virus Surface Antigen (HBsAg) Determine the Antigenicity and Immunogenicity of HBsAg and Influence In Vivo HBsAg Clearance. Journal of Virology. 2012; 86(8):4658-69. doi:10.1128/JVI.06353-11 PMID: 22301154.
39. Li J, Liu Y, Wang Z, Liu K, Wang Y, Liu J, et al. Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment. J Virol. 2011; 85(13):6319-33. PubMed Central PMCID: PMC3126540. doi:10.1128/JVI.02627-10 PMID: 21507968.
40. Wu J, Lu M, Meng Z, Trippler M, Broering R, Szczeponek A, et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology. 2007; 46(6):1769-78. doi:10.1002/hep.21897 PMID: 17929296.
41. Xu S, Pei RJ, Guo M, Han QX, Lai J, Wang Y, et al. Cytosolic Phospholipase A2 Gamma Is Involved in Hepatitis C Virus Replication and Assembly. Journal of Virology. 2012; 86(23):13025-37. doi:10.1128/JVI.01785-12 PMID: 23015700.
42. Li S, Zhao K, Liu S, Wu C, Yao Y, Cao L, et al. HBsAg sT123N mutation induces stronger antibody responses to HBsAg and HBcAg and accelerates in vivo HBsAg clearance. Virus Res. 2015; 210:119- 25. doi:10.1016/j.virusres.2015.08.004 PMID: 26260331.
43. Zhang XY, Liu HY, Xie ZL, Deng WY, Wu CC, Qin B, et al. Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype. Sci Rep-Uk. 2016; 6. doi:ARTN25389.
44. Abe T, Harashima A, Xia T, Konno H, Konno K, Morales A, et al. STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell. 2013; 50(1):5-15. PubMed Central PMCID: PMC3881179. doi:10.1016/j.molcel.2013.01.039 PMID: 23478444.
45. Zhang EJ, Kosinska AD, Ma ZY, Dietze KK, Xu Y, Meng ZJ, et al. Woodchuck hepatitis virus core antigen- based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects. Virology. 2015; 475:56-65. doi:10.1016/j.virol.2014.11.004 PMID: 25462346.
46. Qiao L, Zhang HX, Yu J, Francisco R, Dent P, Ebert MPA, et al. Constitutive activation of NF-kappa B in human hepatocellular carcinoma: Evidence of a cytoprotective role. Hum Gene Ther. 2006; 17(3):280- 90. doi:10.1089/hum.2006.17.280 PMID: 16544977.
47. Pei RJ, Chen XW, Lu MJ. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways. World J Gastroentero. 2014; 20(33):11618-29.
48. Pei RJ, Qin B, Zhang XY, Zhu WD, Kemper T, Ma ZY, et al. Interferon-Induced Proteins with Tetratricopeptide Repeats 1 and 2 Are Cellular Factors That Limit Hepatitis B Virus Replication. J Innate Immun. 2014; 6(2):182-91. doi:10.1159/000353220 PMID: 23867918.
49. Song JJ, Zhou Y, Li S, Wang BJ, Zheng X, Wu J, et al. Susceptibility of Different Hepatitis B Virus Isolates to Interferon-Alpha in a Mouse Model Based on Hydrodynamic Injection. Plos One. 2014; 9(3). doi:ARTNe90977.
50. Biermer M, Puro R, Schneider RJ. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-kappa B. Journal of Virology. 2003; 77 (7):4033-42. doi:10.1128/JVI.77.7.4033-4042.2003 PMID: 12634363.
51. Dansako H, Ueda Y, Okumura N, Satoh S, Sugiyama M, Mizokami M, et al. The cyclic GMP-AMP synthetase- STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly. FEBS J. 2015.
52. Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol. 2004; 5(10):971-4. doi:10.1038/ni1004-971 PMID: 15454919.
53. Hervas-Stubbs S, Riezu-Boj JI, Mancheno U, Rueda P, Lopez L, Alignani D, et al. Conventional but Not Plasmacytoid Dendritic Cells Foster the Systemic Virus-Induced Type I IFN Response Needed for Efficient CD8 T Cell Priming. Journal of Immunology. 2014; 193(3):1151-61.
54. Li XD, Wu J, Gao D, Wang H, Sun L, Chen ZJ. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science. 2013; 341(6152):1390-4. doi:10.1126/science.1244040PMID: 23989956.
55. Thomsen MK, Nandakumar R, Stadler D, Malo A, Valls RM, Wang F, et al. Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection. Hepatology. 2016.
56. Zhu JG, Huang XP, Yang YP. Innate immune response to adenoviral vectors is mediated by both Tolllike receptor-dependent and -independent pathways. Journal of Virology. 2007; 81(7):3170-80. doi:10.1128/JVI.02192-06 PMID: 17229689.
57. Anghelina D, Lam E, Falck-Pedersen E. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity. J Virol. 2016; 90(13):5915-27. PubMed Central PMCID: PMC4907218. doi:10.1128/JVI.00500-16 PMID: 27076643.
58. Toth K, Lee SR, Ying B, Spencer JF, Tollefson AE, Sagartz JE, et al. STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control. PLoS Pathog. 2015; 11(8):e1005084. PubMed Central PMCID: PMC4546297. doi:10.1371/journal.ppat.1005084 PMID: 26291525.
59. Quinn KM, Zak DE, Costa A, Yamamoto A, Kastenmuller K, Hill BJ, et al. Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. J Clin Invest. 2015; 125 (3):1129-46. PubMed Central PMCID: PMC4362254. doi:10.1172/JCI78280 PMID: 25642773.